Literature DB >> 10849728

Modulation of WNT-5A expression by actinonin: linkage of APN to the WNT-pathway?

U Lendeckel1, M Arndt, K Frank, A Spiess, D Reinhold, S Ansorge.   

Abstract

Inhibition of alanyl-aminopeptidase gene expression or enzymatic activity compromises T cell proliferation and function. Molecular mechanisms mediating these effects are not known as yet. Applying the cDNA array technique we identified the proto-oncogen Wnt-5a strongly affected by APN-inhibition. Wnt-5a and other members of the Wnt family of secreted factors are implicated in cell growth and differentiation. Wnt-5a was moderately expressed in resting T cells, but strongly down-regulated in response to activation by OKT3/IL-4/IL-9. Actinonin increased Wnt-5a-mRNA contents as confirmed by RT-PCR. In addition, expression of GSK-3 beta, an inherent component of the Wnt-pathway, was found to be increased in response to activation, but suppressed by actinonin at both the mRNA and protein level. These findings may provide a rationale for the strong growth inhibitory effects resulting from an inhibition of alanyl aminopeptidase expression or activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10849728     DOI: 10.1007/0-306-46826-3_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  A new type of neuron-specific aminopeptidase NAP-2 in rat brain synaptosomes.

Authors:  Maria Hui; Koon-Sea Hui
Journal:  Neurochem Int       Date:  2008-09-11       Impact factor: 3.921

Review 2.  Brain-specific aminopeptidase: from enkephalinase to protector against neurodegeneration.

Authors:  Koon-Sea Hui
Journal:  Neurochem Res       Date:  2007-05-03       Impact factor: 3.996

Review 3.  Amyloid beta peptide-degrading microbial enzymes and its implication in drug design.

Authors:  Maruti J Dhanavade; Kailas D Sonawane
Journal:  3 Biotech       Date:  2020-05-11       Impact factor: 2.406

4.  A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting β-catenin/LEF-1 signaling.

Authors:  Tsung-Hua Hsieh; Chia-Yi Hsu; Cheng-Fang Tsai; Chien-Chih Chiu; Shih-Shin Liang; Tsu-Nai Wang; Po-Lin Kuo; Cheng-Yu Long; Eing-Mei Tsai
Journal:  Sci Rep       Date:  2016-01-11       Impact factor: 4.379

Review 5.  Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.

Authors:  Brigitte Bauvois; Daniel Dauzonne
Journal:  Med Res Rev       Date:  2006-01       Impact factor: 12.944

Review 6.  Opioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them?

Authors:  Magdalena Mizerska-Dudka; Martyna Kandefer-Szerszeń
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-09-06       Impact factor: 4.291

7.  Melatonin Signaling Pathways Implicated in Metabolic Processes in Human Granulosa Cells (KGN).

Authors:  Arjoune Asma; Sirard Marc-André
Journal:  Int J Mol Sci       Date:  2022-03-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.